BioSpace News Archive

Yair Benita, Ph.D., chief technology officer, AION

Novel Alliance Responds to Big Pharma’s Most Pressing AI/ML Needs

AI/ML applications are being deployed at large pharmaceutical companies, but in order to truly maximize their potential, better infrastructure is needed. AION Labs believes it is answering that call.

February 7, 2023

·

5 min read

·

Heather McKenzie

Drug Development

Dragonfly Welcomes BMS-Dropped IL-12 Asset Back into the Fold (Updated)

Bristol Myers Squibb has returned the rights for interleukin-12 immunotherapy program DF6002 back to its original owner, Dragonfly Therapeutics, the companies announced Monday.

February 7, 2023

·

1 min read

·

Rosemary Scott

Advances in Genome Sequencing could Further Precision Cancer Therapies

At the Advances in Genome Biology and Technology general meeting, innovators from industry and academia discuss how recent advances in whole genome sequencing are propelling cancer research.

February 7, 2023

·

4 min read

·

Heather McKenzie

Business

Signs Layoffs may be Coming Soon at Your Job

Though there is no sure-fire tell, there are a few signs to look out for that indicate leadership could be planning to cut staff. Here are the signs layoffs may be coming soon at your organization.

February 7, 2023

·

3 min read

·

Rosemary Scott

Courtesy Smith Collection/Gado/Getty Images

Drug Development

Roche Goes Toe-to-Toe with AstraZeneca’s Soliris in PNH

Data from a Phase III study show Genentech’s crovalimab is non-inferior to AstraZeneca’s Soliris, the current standard of care in paroxysmal nocturnal hemoglobinuria (PNH).

February 7, 2023

·

2 min read

·

Tristan Manalac

Business

Merck and Nectin to Study Novel Anti-PVR Candidate with Keytruda

Merck and Nectin Therapeutics announced a research collaboration agreement to study the safety and efficacy of Nectin’s investigational antibody in locally advanced and metastatic solid tumors.

February 7, 2023

·

2 min read

·

Tristan Manalac

Drug Development

Genentech Announces Positive Data From Global Phase III Program for Crovalimab in PNH, a Rare, Life-Threatening Blood Condition

Genentech, a member of the Roche Group, announced positive results from the global Phase III COMMODORE 2 study, evaluating the efficacy and safety of crovalimab in people with paroxysmal nocturnal hemoglobinuria who have not been previously treated with complement inhibitors.

February 7, 2023

·

5 min read

Bio NC

Continued strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers second sales milestone payment to Basilea from Pfizer

Basilea Pharmaceutica Ltd. announced that the continued strong sales performance of the antifungal Cresemba® by its license partner Pfizer Inc. in the Asia Pacific region and China exceeded the threshold triggering a sales milestone payment of USD 1.25 million.

February 7, 2023

·

4 min read

Business

Evotec SE: Laetitia Rouxel to succeed Enno Spillner as Chief Financial Officer

Evotec SE announced that the Company’s Supervisory Board has appointed Laetitia Rouxel as new Chief Financial Officer and member of the Management Board effective 01 April 2023.

February 7, 2023

·

5 min read

Genetown

CureVac Announces Proposed Public Offering of Common Shares - February 07, 2023

CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid, announced that it intends to offer $200 million of its common shares in an underwritten public offering.

February 7, 2023

·

6 min read